Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan

Microbial Drug Resistance

Volumn 19, Issue 4, 2013, Pages 308-315

  Chiba, Naoko ^a   Morozumi, Miyuki ^a   Shouji, Michi ^b   Wajima, Takeaki ^a   Iwata, Satoshi ^c   Sunakawa, Keisuke ^d   Ubukata, Kimiko ^a  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CHILD; GENOTYPE; HUMAN; IMMUNIZATION; JAPAN; MAJOR CLINICAL STUDY; MENINGITIS; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEPSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INFANT; JAPAN; MALE; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEPSIS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 84880860044     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0180     Document Type: Article

References (28)

1. Advisory Committee on Immunization Practices (ACIP). 2000. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 49:1-35.
2. Appelbaum, P.C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
3. Brueggemann, A.B., R. Pai, D.W. Crook, and B. Beall. 2007. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 3: e168.
4. Centers for Disease Control and Prevention (CDC). 2005. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR. Morb. Mortal Wkly. Rep. 54:893-897.
5. Centers for Disease Control and Prevention (CDC). 2010. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children-Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. Morb. Mortal Wkly. Rep. 59:258-261.
6. Chiba, N., R. Kobayashi, K. Hasegawa, M. Morozumi, E. Nakayama, T. Tajima, S. Iwata, and K. Ubukata. 2005. Antibiotic susceptibility according to genotype of penicillinbinding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from communityacquired pneumonia in children. J. Antimicrob. Chemother. 56:756-760. (Pubitemid 41487779)
7. Chiba, N., M. orozumi, and K. Ubukata. 2012. Application of the real-time PCR method for genotypic identification of beta-lactam resistance in isolates from invasive pneumococcal diseases. Microb. Drug Resist. 18:149-156.
8. Choi, Y.H., M. Jit, S. Flasche, N. Gay, and E. Miller. 2012. Mathematical modelling long-term effects of replacing prevnar7 with prevnar13 on invasive pneumococcal diseases in England and wales. PloS One 7:e39927.
9. Dagan, R., and K.P. Klugman. 2008. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet. Infect. Dis. 8:785-795.
10. Demczuk, W.H., I. Martin, A. Griffith, B. Lefebvre, A. McGeer, A. Shane, G.G. Zhanel, G.J. Tyrrell, M.W. Gilmour; Toronto Invasive Bacterial Diseases Network, and Canadian Public Health Laboratory Network. 2012. Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010. Can. J. Microbiol. 58:1008-1017.
11. Enright, M.C., and B.G. Spratt. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144 (Pt 11):3049-3060. (Pubitemid 28515583)
12. Farrell, D.J., K.P. Klugman, and M. Pichichero. 2007. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26: 123-128. (Pubitemid 46183361)
13. Gertz, R.E., Jr., Z. Li, F.C. Pimenta, D. Jackson, B.A. Juni, R. Lynfield, J.H. Jorgensen, G. Carvalho Mda, and B.W. Beall. 2010. Increased penicillin nonsusceptibility of nonvaccineserotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J. Infect. Dis. 201:770-775.
14. Hanage, W.P., S.S. Huang, M. Lipsitch, C.J. Bishop, D. Godoy, S.I. Pelton, R. Goldstein, H. Huot, and J.A. Finkelstein. 2007. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 195:347-352. (Pubitemid 46146111)
15. Isaacman, D.J., E.D. McIntosh, and R.R. Reinert. 2010. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int. J. Infect. Dis. 14:e197-e209.
16. Jefferies, J.M., A.J. Smith, G.F. Edwards, J. McMenamin, T.J. Mitchell, and S.C. Clarke. 2010. Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine. J. Clin. Microbiol. 48:87-96.
17. Klugman, K.P. 2001. Antibiotic selection of multiply resistant pneumococci. Clin. Infect. Dis. 33:489-491. (Pubitemid 32709581)
18. McIntosh, E.D., and R.R. Reinert. 2011. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev. Vaccines 10:109-129.
19. O'Brien, K.L., L.J. Wolfson, J.P. Watt, E. Henkle, M. Deloria-Knoll, N. McCall, E. Lee, K. Mulholland, O.S. Levine, and T. Cherian. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893-902.
20. Pebody, R.G., W. Hellenbrand, F. D'Ancona, and P. Ruutu. 2006. Pneumococcal disease surveillance in Europe. Euro. Surveill. 11:171-178.
21. Pilishvili, T., C. Lexau, M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, A. Reingold, A. Thomas, W. Schaffner, A.S. Craig, P.J. Smith, B.W. Beall, C.G. Whitney, M.R. Moore; Active Bacterial Core Surveillance/Emerging Infections Program Network. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201:32-41.
22. Poehling, K.A., T.R. Talbot, M.R. Griffin, A.S. Craig, C.G. Whitney, E. Zell, C.A. Lexau, A.R. Thomas, L.H. Harrison, A.L. Reingold, J. L. Hadler, M. M. Farley, B. J. Anderson, and W. Schaffner. 2006. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 295:1668-1674.
23. Rennels, M.B., K.M. Edwards, H.L. Keyserling, K.S. Reisinger, D.A. Hogerman, D.V. Madore, I. Chang, P.R. Paradiso, F.J. Malinoski, and A. Kimura. 1998. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101:604-611. (Pubitemid 28180141)
24. Rosen, J.B., A.R. Thomas, C.A. Lexau, A. Reingold, J.L. Hadler, L.H. Harrison, N.M. Bennett, W. Schaffner, M.M. Farley, B.W. Beall and M. R. Moore. 2011. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin. Infect. Dis. 53:137-143.
25. Sakai, F., N. Chiba, A. Ono, S. Yamagata Murayama, K. Ubukata, K. Sunakawa, and T. Takahashi. 2011. Molecular epidemiologic characteristics of Streptococcus pneumoniae isolates from children with meningitis in Japan from 2007 through 2009. J. Infect. Chemother. 17:334-340.
26. Ubukata, K., Y. Asahi, K. Okuzumi, and M. Konno. 1996. Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993-1995. J. Infect. Chemother. 1:177-184.
27. Ubukata, K., N. Chiba, K. Hasegawa, R. Kobayashi, S. Iwata, and K. Sunakawa. 2004. Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002. Antimicrob Agents Chemother. 48:1488-1494. (Pubitemid 38544349)
28. World Health Organization (WHO). 2007. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly. Epidemiol. Rec. 82:93-104.